Medically reviewed by Dr. Tom Biernacki, DPM — Board-Certified Podiatric Surgeon — Balance Foot & Ankle, Howell & Bloomfield Hills, MI. Last updated April 2026.

Surgical Cartilage Restoration for Ankle Osteochondral Defects

Articular cartilage — the smooth, glistening tissue that covers joint surfaces — has extremely limited natural healing capacity. Unlike bone, which can regenerate through a robust healing response, cartilage lacks blood vessels and depends on nutrient diffusion from joint fluid for survival. When cartilage is damaged in the ankle by trauma, repetitive stress, or osteochondral lesion, the body cannot spontaneously regenerate the same high-quality hyaline cartilage that was lost. Without treatment, cartilage defects progress and accelerate arthritis development.

Surgical cartilage restoration aims to either stimulate new cartilage tissue formation or transplant healthy cartilage to fill the defect. At Balance Foot & Ankle, our foot and ankle surgeons are experienced in all major cartilage restoration techniques and match the procedure to each patient defect characteristics, age, activity demands, and prior treatment history.

Preoperative Planning

Careful preoperative planning determines which cartilage restoration technique is most appropriate. Key factors include defect size (smaller defects respond well to bone marrow stimulation; larger defects require cell-based or osteochondral graft techniques), lesion depth (purely cartilaginous versus those extending into subchondral bone), cyst formation beneath the lesion, defect location on the talar dome (centrally located versus shoulder lesions have different access and outcome profiles), patient age and biological healing potential, activity demands, and prior treatment history.

MRI characterizes cartilage integrity and the extent of subchondral involvement. Weight-bearing CT scan provides precise three-dimensional size measurement and identifies subchondral cysts that may require bone grafting concurrent with cartilage repair. These imaging findings directly guide the surgical approach.

Arthroscopic Debridement and Microfracture

For lesions smaller than approximately 1.5 cm in diameter without significant cyst formation, arthroscopic microfracture is the standard first-line treatment. The procedure is performed entirely through small arthroscopic portals without opening the ankle joint.

The unstable cartilage is debrided using arthroscopic shavers and curettes until a stable cartilage edge surrounds the defect. The underlying calcified cartilage layer is removed with a curette, preparing the bone surface for new tissue attachment. An arthroscopic awl is used to create multiple perforations through the subchondral bone plate at 3 to 4 millimeter intervals. These perforations access the subchondral bone marrow, releasing mesenchymal stem cells, growth factors, and blood that fill the defect with a superclot.

Over 6 to 8 weeks, the superclot matures into a fibrocartilage tissue — mechanically functional but composed of type I collagen rather than the type II collagen of native hyaline cartilage. Fibrocartilage is less stiff and wears more quickly than hyaline cartilage, explaining why microfracture outcomes tend to deteriorate for larger defects over time.

Recovery requires 4 to 6 weeks of non-weight bearing to protect the maturing clot, followed by progressive weight bearing and physical therapy. Return to full athletic activity typically requires 4 to 6 months.

Osteochondral Autograft Transfer System (OATS)

OATS transfers one or more cylindrical plugs of bone and articular cartilage from a non-weight-bearing area of the knee (typically the lateral trochlea or intercondylar notch) to the ankle defect. The transplanted cartilage is true hyaline cartilage — the same tissue type as the native talar dome — providing superior mechanical properties compared to the fibrocartilage from microfracture.

OATS is indicated for lesions of 1.5 to 2.5 cm in diameter where microfracture would likely yield inferior results, for cystic lesions requiring bone grafting, and for revision of failed prior bone marrow stimulation. The procedure may be performed arthroscopically or through a small open approach (miniarthrotomy) depending on defect location and size.

The harvest from the knee creates a donor site defect that fills with fibrocartilage over time. Donor site pain and stiffness affect some patients temporarily but significant long-term donor site morbidity is uncommon. Careful graft sizing and seating is critical — proud grafts (those that sit too high in the recipient site) accelerate wear of the opposing tibial cartilage.

Recovery after OATS is similar to microfracture in timeline, with 4 to 6 weeks of non-weight bearing protecting the graft incorporation period followed by progressive rehabilitation. Full return to sport requires 6 to 9 months.

BioCartilage Augmentation

BioCartilage (Arthrex) is a particulated extracellular cartilage matrix derived from cadaveric cartilage and dehydrated into a powder or putty form. Mixed with platelet-rich plasma (PRP) and packed into the microfracture defect, it provides a three-dimensional scaffold that promotes more organized fibrocartilage tissue formation compared to microfracture alone.

BioCartilage augments — rather than replaces — the microfracture technique, providing a single-stage procedure with improved tissue quality compared to standard microfracture. It is appropriate for lesions in the 1.0 to 2.0 cm range where microfracture alone would be expected to yield suboptimal results but OATS is not yet required. Intermediate-term results are promising, though long-term comparative data with OATS and cell-based techniques is still accumulating.

Autologous Chondrocyte Implantation (ACI and MACI)

For large defects (greater than 2.5 cm), failed prior cartilage procedures, or patients for whom maximum cartilage quality is the priority, cell-based techniques including autologous chondrocyte implantation (ACI) and matrix-induced ACI (MACI) provide the most biologically advanced restoration possible.

ACI/MACI is a two-stage procedure. In Stage 1, a small cartilage biopsy is harvested arthroscopically from a non-weight-bearing knee area and sent to a laboratory where the chondrocytes are grown in culture for 4 to 6 weeks, expanding the cell population dramatically. In Stage 2, the cultured cells are implanted into the ankle defect — either under a periosteal patch (ACI) or seeded onto a collagen scaffold that is sutured into the defect (MACI).

The implanted cells mature over 12 to 18 months into hyaline-like cartilage. Long-term outcomes for ACI/MACI in the ankle are superior to microfracture for large defects, though the two-stage nature, specialized laboratory processing, and higher cost limit its use to appropriately selected cases.

Choosing the Right Cartilage Repair Approach

The optimal approach is determined by defect characteristics, not by patient or surgeon preference alone. Defects under 1.0 cm in a young, active patient: microfracture. Defects 1.0 to 1.5 cm with BioCartilage augmentation as a single-stage enhancement. Defects 1.5 to 2.5 cm with cystic changes: OATS. Defects greater than 2.5 cm or failed prior procedures: MACI or ACI. Concurrent alignment problems must be corrected simultaneously to prevent overloading the repair site.

Contact Balance Foot & Ankle for comprehensive evaluation of persistent ankle pain, especially following prior ankle injuries. Our foot and ankle surgeons provide expert assessment and individualized treatment planning, including all modern cartilage restoration techniques, for patients throughout Southeast Michigan.

Ready to Relieve Your Foot Pain?

Board-certified podiatrists serving Southeast Michigan. Same-week appointments available.

Book Your Appointment

Ankle Cartilage Repair Surgery at Balance Foot & Ankle

Ankle cartilage damage (osteochondral lesions) can cause chronic pain and instability if untreated. Dr. Tom Biernacki at Balance Foot & Ankle performs microfracture, OAT grafting, and other cartilage restoration procedures at our Howell and Bloomfield Hills offices.

Learn About Our Ankle Surgery Options | Book Your Appointment | Call (810) 206-1402

Clinical References

1. Zengerink M, et al. “Treatment of osteochondral lesions of the talus: a systematic review.” Knee Surgery, Sports Traumatology, Arthroscopy. 2010;18(2):238-246.
2. Chuckpaiwong B, et al. “Microfracture for osteochondral lesions of the ankle.” Arthroscopy. 2008;24(1):106-112.
3. Savage-Elliott I, et al. “Osteochondral lesions of the talus: a current concepts review.” Foot and Ankle Specialist. 2014;7(5):414-422.